The UroLume® Urethral Stent from AMS is the only FDA-approved long-term (yet reversible) treatment alternative to sphincterotomy (removal of the detrusor external sphincter).
Five years of follow-up from clinical trials have proven its safety and effectiveness. ¹
1. Chancellor MB, Gajewski J, Ackman CF, Appell RA, Bennett J, Binard J, Boone TB, Chetner MP, Crewalk JA, Defalco A, Foote J, Green B, Juma S, Jung SY, Linsenmeyer TA, MacMillan R, Mayo M, Ozawa H, Roehrborn CG, Shenot PJ, Stone A, Vazquez A, Killorin W, Rivas DA. Long-term followup of the North American multicenter UroLume trial for the treatment of external detrusor-sphincter dyssynergia. J Urol May 1999 v. 161(5) p.1545-50. |
